Wierzbicki, P. M., Klacz, J., Kotulak-Chrzaszcz, A., Wronska, A., Stanislawowski, M., Rybarczyk, A., . . . Matuszewski, M. (2019). wPrognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear-cell renal cell carcinoma treated with sunitinib as first-line treatment. Int J Oncol.
Chicago Stili AlıntıWierzbicki, Piotr M., Jakub Klacz, Anna Kotulak-Chrzaszcz, Agata Wronska, Marcin Stanislawowski, Agnieszka Rybarczyk, Aleksandra Ludziejewska, Zbigniew Kmiec, ve Marcin Matuszewski. "WPrognostic Significance of VHL, HIF1A, HIF2A, VEGFA and P53 Expression in Patients With Clear-cell Renal Cell Carcinoma Treated With Sunitinib As First-line Treatment." Int J Oncol 2019.
MLA AlıntıWierzbicki, Piotr M., et al. "WPrognostic Significance of VHL, HIF1A, HIF2A, VEGFA and P53 Expression in Patients With Clear-cell Renal Cell Carcinoma Treated With Sunitinib As First-line Treatment." Int J Oncol 2019.